Cargando…

Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics

Hearing impairment is the most common sensory disorder in humans, and yet hardly any medications are licensed for the treatment of inner ear pathologies. Intricate pharmacokinetic examinations to better understand drug distribution within this complex organ could facilitate the development of novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yildiz, Erdem, Gadenstaetter, Anselm J., Gerlitz, Matthias, Landegger, Lukas D., Liepins, Rudolfs, Nieratschker, Michael, Glueckert, Rudolf, Staecker, Hinrich, Honeder, Clemens, Arnoldner, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034346/
https://www.ncbi.nlm.nih.gov/pubmed/36969846
http://dx.doi.org/10.3389/fphar.2023.1062379
_version_ 1784911197419601920
author Yildiz, Erdem
Gadenstaetter, Anselm J.
Gerlitz, Matthias
Landegger, Lukas D.
Liepins, Rudolfs
Nieratschker, Michael
Glueckert, Rudolf
Staecker, Hinrich
Honeder, Clemens
Arnoldner, Christoph
author_facet Yildiz, Erdem
Gadenstaetter, Anselm J.
Gerlitz, Matthias
Landegger, Lukas D.
Liepins, Rudolfs
Nieratschker, Michael
Glueckert, Rudolf
Staecker, Hinrich
Honeder, Clemens
Arnoldner, Christoph
author_sort Yildiz, Erdem
collection PubMed
description Hearing impairment is the most common sensory disorder in humans, and yet hardly any medications are licensed for the treatment of inner ear pathologies. Intricate pharmacokinetic examinations to better understand drug distribution within this complex organ could facilitate the development of novel therapeutics. For such translational research projects, animal models are indispensable, but differences in inner ear dimensions and other anatomical features complicate the transfer of experimental results to the clinic. The gap between rodents and humans may be bridged using larger animal models such as non-human primates. However, their use is challenging and impeded by administrative, regulatory, and financial hurdles. Other large animal models with more human-like inner ear dimensions are scarce. In this study, we analyzed the inner ears of piglets as a potential representative model for the human inner ear and established a surgical approach for intracochlear drug application and subsequent apical sampling. Further, controlled intracochlear delivery of fluorescein isothiocyanate-dextran (FITC-d) was carried out after the insertion of a novel, clinically applicable CE-marked cochlear catheter through the round window membrane. Two, six, and 24 hours after a single injection with this device, the intracochlear FITC-d distribution was determined in sequential perilymph samples. The fluorometrically assessed concentrations two hours after injection were compared to the FITC-d content in control groups, which either had been injected with a simple needle puncture through the round window membrane or the cochlear catheter in combination with a stapes vent hole. Our findings demonstrate not only significantly increased apical FITC-d concentrations when using the cochlear catheter but also higher total concentrations in all perilymph samples. Additionally, the concentration decreased after six and 24 hours and showed a more homogenous distribution compared to shorter observation times.
format Online
Article
Text
id pubmed-10034346
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100343462023-03-24 Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics Yildiz, Erdem Gadenstaetter, Anselm J. Gerlitz, Matthias Landegger, Lukas D. Liepins, Rudolfs Nieratschker, Michael Glueckert, Rudolf Staecker, Hinrich Honeder, Clemens Arnoldner, Christoph Front Pharmacol Pharmacology Hearing impairment is the most common sensory disorder in humans, and yet hardly any medications are licensed for the treatment of inner ear pathologies. Intricate pharmacokinetic examinations to better understand drug distribution within this complex organ could facilitate the development of novel therapeutics. For such translational research projects, animal models are indispensable, but differences in inner ear dimensions and other anatomical features complicate the transfer of experimental results to the clinic. The gap between rodents and humans may be bridged using larger animal models such as non-human primates. However, their use is challenging and impeded by administrative, regulatory, and financial hurdles. Other large animal models with more human-like inner ear dimensions are scarce. In this study, we analyzed the inner ears of piglets as a potential representative model for the human inner ear and established a surgical approach for intracochlear drug application and subsequent apical sampling. Further, controlled intracochlear delivery of fluorescein isothiocyanate-dextran (FITC-d) was carried out after the insertion of a novel, clinically applicable CE-marked cochlear catheter through the round window membrane. Two, six, and 24 hours after a single injection with this device, the intracochlear FITC-d distribution was determined in sequential perilymph samples. The fluorometrically assessed concentrations two hours after injection were compared to the FITC-d content in control groups, which either had been injected with a simple needle puncture through the round window membrane or the cochlear catheter in combination with a stapes vent hole. Our findings demonstrate not only significantly increased apical FITC-d concentrations when using the cochlear catheter but also higher total concentrations in all perilymph samples. Additionally, the concentration decreased after six and 24 hours and showed a more homogenous distribution compared to shorter observation times. Frontiers Media S.A. 2023-03-09 /pmc/articles/PMC10034346/ /pubmed/36969846 http://dx.doi.org/10.3389/fphar.2023.1062379 Text en Copyright © 2023 Yildiz, Gadenstaetter, Gerlitz, Landegger, Liepins, Nieratschker, Glueckert, Staecker, Honeder and Arnoldner. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yildiz, Erdem
Gadenstaetter, Anselm J.
Gerlitz, Matthias
Landegger, Lukas D.
Liepins, Rudolfs
Nieratschker, Michael
Glueckert, Rudolf
Staecker, Hinrich
Honeder, Clemens
Arnoldner, Christoph
Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
title Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
title_full Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
title_fullStr Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
title_full_unstemmed Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
title_short Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
title_sort investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034346/
https://www.ncbi.nlm.nih.gov/pubmed/36969846
http://dx.doi.org/10.3389/fphar.2023.1062379
work_keys_str_mv AT yildizerdem investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT gadenstaetteranselmj investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT gerlitzmatthias investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT landeggerlukasd investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT liepinsrudolfs investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT nieratschkermichael investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT glueckertrudolf investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT staeckerhinrich investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT honederclemens investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics
AT arnoldnerchristoph investigationofinnereardrugdeliverywithacochlearcatheterinpigletsasarepresentativemodelforhumancochlearpharmacokinetics